The value of HMBE-1, calretinin and cytokeratin5/6 for diagnosis of epitheloid malignant mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 82s Year: 2006
The diagnostic value of mucinous carcinoma - associated antigen (MCA) testin differentiation of malignant from benign pleural effusion (PE) Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003
Diagnostic problems in benign and malignant pleural effusions Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today Year: 2007
Distinction in immunoprofile of unusual lung tumours Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin Source: Eur Respir J 2007; 30: Suppl. 51, 431s Year: 2007
The reliability of the cytological diagnosis malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Atypical mesothelial hyperplasia and other pitfalls in MPE diagnosis Source: International Congress 2015 – PG10 Malignant pleural effusion management Year: 2015
Mesothelial reactive hyperplasia of the pleura: the dilemma between a malign or benign disease Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
The expression of Ki-67 in preneoplastic and early neoplastic bronchial lesions Source: Eur Respir J 2002; 20: Suppl. 38, 229s Year: 2002
The expression of Ki-67 in preneoplastic and early neoplastic bronchial lesions Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
The role of 99m-Tc-Depreotide scintigraphy in discriminating between malignant and benign pulmonary nodules Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005
Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
The importance of radiological findings to distinguish benign and malignant pleural diseases Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases Year: 2008
Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma? Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Clinical prognostic indicators of high-grade pre-invasive bronchial lesions Source: Eur Respir J 2004; 24: 24-29 Year: 2004
The differential diagnosis of pulmonary pre-invasive lesions Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=37 Year: 2007
Diagnostic utility of CYFRA 21-1 and carcinoembryonic antigen as a tumour markers in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
Expression of c-met in malignant pleural mesothelioma; an immunohistochemical study Source: Annual Congress 2007 - Inorganic dust "old timers and new kids on the block" Year: 2007
Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003